Cognition Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Cognition Therapeutics, Inc. (CGTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$482.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$346.00K.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$136.00K.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$473.00K.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$47.00K.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.17M.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.63M.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.85M, a 242.24% decline from fiscal 2022.
- Cognition Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.30M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$346.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$482.00K 10-Q · filed 2026-08-07 | -$955.00K derived: sum of 3 quarters · filed 2026-08-07 | -$1.00M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$136.00K 10-Q · filed 2026-05-08 | -$609.00K derived: sum of 2 quarters · filed 2026-05-08 | -$656.00K derived: sum of 3 quarters · filed 2026-05-08 | -$1.11M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$520.00K derived: sum of 2 quarters · filed 2026-03-26 | -$973.00K derived: sum of 3 quarters · filed 2026-08-07 | -$1.17M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$500.00K derived: sum of 2 quarters · filed 2026-08-07 | -$700.00K 10-Q · filed 2025-11-06 | -$764.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$453.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$653.00K 10-Q · filed 2026-08-07 | -$717.00K derived: sum of 3 quarters · filed 2026-08-07 | -$1.19M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$200.00K 10-Q · filed 2026-05-08 | -$264.00K derived: sum of 2 quarters · filed 2026-05-08 | -$732.00K derived: sum of 3 quarters · filed 2026-05-08 | -$1.25M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$532.00K derived: sum of 2 quarters · filed 2026-03-26 | -$1.05M derived: sum of 3 quarters · filed 2026-03-26 | -$1.63M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$986.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.57M 10-Q · filed 2025-11-06 | -$2.46M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.10M 10-Q · filed 2025-08-07 | -$1.99M derived: sum of 3 quarters · filed 2025-08-07 | -$2.20M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$583.00K 10-Q · filed 2025-05-07 | -$1.47M derived: sum of 2 quarters · filed 2025-05-07 | -$1.68M derived: sum of 3 quarters · filed 2025-05-07 | -$2.51M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$1.10M derived: sum of 2 quarters · filed 2025-03-20 | -$1.92M derived: sum of 3 quarters · filed 2025-03-20 | -$1.85M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.03M derived: sum of 2 quarters · filed 2024-11-13 | -$962.00K 10-Q · filed 2024-11-13 | -$957.00K 10-Q · filed 2023-11-02 | -$1.14M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$824.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$752.00K 10-Q · filed 2024-08-08 | -$927.00K derived: sum of 3 quarters · filed 2024-08-08 | $60.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $72.00K 10-Q · filed 2024-05-07 | -$103.00K derived: sum of 2 quarters · filed 2024-05-07 | $884.00K derived: sum of 3 quarters · filed 2024-05-07 | $292.00K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $812.00K derived: sum of 2 quarters · filed 2024-03-26 | $220.00K derived: sum of 3 quarters · filed 2024-03-26 | $1.30M 10-K · filed 2024-03-26 | -$430.00K 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $987.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $395.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.48M 10-Q · filed 2023-11-02 | $1.44M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $490.00K 10-Q · filed 2023-08-08 | $957.00K 10-Q · filed 2022-08-09 | $451.00K derived: sum of 3 quarters · filed 2023-08-08 | $199.00K derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $1.08M 10-Q · filed 2023-05-04 | $132.00K 10-Q · filed 2022-05-11 | $1.04M derived: sum of 2 quarters · filed 2023-05-04 | $791.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.37M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$291.00K derived: sum of 2 quarters · filed 2023-03-23 | $284.00K derived: sum of 3 quarters · filed 2023-03-23 | -$21.00K 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $323.00K derived: sum of 2 quarters · filed 2022-11-14 | $18.00K 10-Q · filed 2022-11-14 | $221.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $575.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $270.00K 10-Q · filed 2022-08-09 | $473.00K derived: sum of 3 quarters · filed 2022-08-09 | |||||
| 2021-03-31 | -$305.00K 10-Q · filed 2022-05-11 | -$102.00K derived: sum of 2 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $417.00K 10-K · filed 2022-03-30 | ||||||
| 2020-09-30 | $214.00K 10-Q · filed 2021-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |